Steadfast Invests Over ₹100 Crore in Integrated Nutraceutical Manufacturing and R&D Facility in Noida
Steadfast Ltd., a pharmaceutical and nutraceutical company, has invested over ₹100 crore to set up an integrated manufacturing and research facility in Noida, Uttar Pradesh. The facility has an in-house Formulation Research and Development (FR&D) centre, a nutraceutical manufacturing plant and an advanced quality control laboratory.
The plant makes dietary supplements as tablets, powders, effervescent tablets and capsules. Annual capacity is 900 million tablets, 130 million capsules, 900 million effervescent tablets and 6,500 tonnes of powders. The facility is automated and holds an FSSAI licence. It has been developed in line with WHO-GMP guidelines.
The quality control laboratory has more than 140 analytical instruments from Indian and international manufacturers. It is undergoing accreditation by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Steadfast says the integrated set-up brings research, production and quality testing under one roof. The company’s CEO, Aman Puri, said the investment would support domestic production and reduce import dependence in nutraceuticals.
